Literature DB >> 3584182

Intramedullary haemorrhage as a possible cause of avascular necrosis of the femoral head. The histology of 16 femoral heads at the silent stage.

S Saito, A Inoue, K Ono.   

Abstract

We have studied core biopsy specimens from 16 femoral heads affected by idiopathic avascular necrosis at the silent stage, when there were no clinical or radiographic manifestations but scintigraphy was positive. All the specimens showed necrosis of trabeculae and of bone marrow, but the most common and characteristic feature was evidence of old and new haemorrhage in the marrow. In the areas of intramedullary haemorrhages, trabeculae and bone marrow were completely necrotic, with a transitional area of incomplete necrosis between these areas and those without haemorrhagic lesions, where the trabeculae and bone marrow were normal. There was good correlation between necrosis and haemorrhagic episodes, and it was concluded that repeated intramedullary haemorrhage at the silent stage is probably related to the pathogenesis of idiopathic avascular necrosis of the femoral head.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3584182

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  10 in total

1.  Will a vascularized greater trochanter graft preserve the necrotic femoral head?

Authors:  Dewei Zhao; Benjie Wang; Lin Guo; Lei Yang; Fengde Tian
Journal:  Clin Orthop Relat Res       Date:  2009-11-07       Impact factor: 4.176

2.  The use of joint-specific and whole-body MRI in osteonecrosis: a study in patients with juvenile systemic lupus erythematosus.

Authors:  T C M Castro; H Lederman; M T A Terreri; W I Caldana; S C Kaste; M O Hilário
Journal:  Br J Radiol       Date:  2010-11-16       Impact factor: 3.039

3.  In vivo demonstration of enhanced radiotherapy using rare earth doped titania nanoparticles.

Authors:  Helen E Townley; Jeewon Kim; Peter J Dobson
Journal:  Nanoscale       Date:  2012-07-06       Impact factor: 7.790

4.  Osteocytic cell necrosis is caused by a combination of glucocorticoid-induced Dickkopf-1 and hypoxia.

Authors:  Shusuke Ueda; Toru Ichiseki; Yasuo Yoshitomi; Hideto Yonekura; Yoshimichi Ueda; Ayumi Kaneuji; Tadami Matsumoto
Journal:  Med Mol Morphol       Date:  2014-05-13       Impact factor: 2.309

5.  Heme oxygenase-1 prevents glucocorticoid and hypoxia-induced apoptosis and necrosis of osteocyte-like cells.

Authors:  Hiroki Yamamoto; Masazumi Saito; Tsuyoshi Goto; Keiichiro Ueshima; Masashi Ishida; Shigeki Hayashi; Kazuya Ikoma; Osam Mazda; Toshikazu Kubo
Journal:  Med Mol Morphol       Date:  2019-01-31       Impact factor: 2.309

6.  Histopathology of the vessels of the femoral heads in specimens of osteonecrosis, osteoarthritis and algodystrophy.

Authors:  J Arlet; M Laroche; R Soler; M Thiechart; M T Pieraggi; B Mazières
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

7.  MRI fluid sign is reliable in correlation with osteonecrosis after vertebral fractures: a histopathologic study.

Authors:  Cheng-Li Lin; Ruey-Mo Lin; Kuo-Yuan Huang; Jing-Jou Yan; Yu-Shan Yan
Journal:  Eur Spine J       Date:  2012-12-27       Impact factor: 3.134

8.  Early Steroid-Induced Osteonecrosis of Rabbit Femoral Head and Panax notoginseng Saponins: Mechanism and Protective Effects.

Authors:  Hui Qiang; Huitong Liu; Ming Ling; Kunzheng Wang; Chen Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-16       Impact factor: 2.629

9.  Treatment of steroid-induced osteonecrosis of the femoral head using porous Se@SiO2 nanocomposites to suppress reactive oxygen species.

Authors:  Guoying Deng; Kerun Niu; Feng Zhou; Buxiao Li; Yingjie Kang; Xijian Liu; Junqing Hu; Bo Li; Qiugen Wang; Chengqing Yi; Qian Wang
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

10.  Pathogenesis of the intravertebral vacuum of Kümmell's disease.

Authors:  Dengwei He; Weiyang Yu; Zhenzhong Chen; Liangchen Li; Kejun Zhu; Shunwu Fan
Journal:  Exp Ther Med       Date:  2016-05-19       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.